Análisis Argos
ADUS
ADUSEn su precio
Addus HomeCare Corporation · Healthcare
US$ 109.72
precio al 2026-07-09
Valor justo Argos*
US$ 105–116
vs. su valor justo
5% por debajo
Score Argos
70/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (9.2%) en línea con lo que la empresa demuestra (9.9%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Cotiza 21% por debajo de su valor justo.
Las ganancias crecieron 30% el último año.
Riesgos
Sin riesgos destacados.
VALOR3/6FUTURO3/6PASADO4/6SALUD5/6DIVIDENDO1/6
El Iris de calidad
VALOR3/6FUTURO3/6PASADO4/6SALUD5/6DIVIDENDO1/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance fuerte, deuda controlada
DividendoEl dividendo aún duerme
Score Argos70de 100En su precio
Ingresos23%
US$ 1.4 B
Margen operativo9%
9.7%
Flujo de caja libre9%
US$ 0.1 B
Deuda neta
US$ 0.1 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.0B
P/E21.4x
EV/EBITDA14x
FCF yield5.1%
ROIC8.6%
Margen operativo9.7%
Crecim. ingresos+23.2%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

seekingalpha.com · 23 may
Addus HomeCare: Strong Position Amid An Opportunistic Market
ADUS's business model has structural advantages that will allow it to withstand sector-wide pressures. With the federal crackdown among self-directed operators, ADUS is in a position to acquire client books for cheaper. As the US population ages and federal policies continue to pressure state budgets, ADUS stands to increasingly benefit from higher allocation to home care in its leading markets.
fool.com · 19 may
Bridge City Nearly Tripled Its Addus Position — Into a Down Stock
This healthcare provider delivers personal care, hospice, and home health services across 22 states, targeting vulnerable populations.
marketbeat.com · 19 may
Addus HomeCare Says License Moratorium Won't Slow Personal Care Growth, M&A
Addus HomeCare NASDAQ: ADUS executives said a new federal moratorium on certain home health licenses should have little effect on the company's growth plans, while highlighting continued improvement in personal care services trends and ongoing acquisition opportunities.
seekingalpha.com · 12 may
Addus HomeCare Corporation (ADUS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Addus HomeCare Corporation (ADUS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com · 5 may
Addus HomeCare Corporation (ADUS) Q1 2026 Earnings Call Transcript
Addus HomeCare Corporation (ADUS) Q1 2026 Earnings Call Transcript
businesswire.com · 5 may
Addus HomeCare to Participate in Upcoming Investor Conferences in May
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2026 Health Care Conference in Las Vegas, Nevada, on Tuesday, May 12, 2026. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 4:40 p.m. Pacific Time / 6:.
zacks.com · 4 may
Addus HomeCare (ADUS) Q1 Earnings Top Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.52 per share. This compares to earnings of $1.42 per share a year ago.
zacks.com · 4 may
Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.